FTC FTC Announces $40 Million Settlement with Vyera Pharmaceuticals Thomas Sullivan Dec 13, 2021 0 In early December 2021, the United States Federal Trade Commission (FTC), along with several state co-plaintiffs (New York,…
Accountable Care Organizations ACOs Saved Medicare More than $4 Billion in 2020 Thomas Sullivan Dec 10, 2021 0 According to data recently released by the Centers for Medicare and Medicaid Services (CMS) accountable care organizations (ACOs)…
FDA Becerra Reinstates FDA Rulemaking Authority Thomas Sullivan Dec 9, 2021 0 On August 30, 2021, Health and Human Services (HHS) Secretary Xavier Becerra issued a Notice that reversed former HHS Secretary…
Uncategorized FDA Issues Notice on Implementation of Genus Decision Thomas Sullivan Dec 8, 2021 0 In early August 2021, the United States Food and Drug Administration (FDA) posted a Notice in the Federal Register about its…
CMS CMS Delays Enforcement of Certain “Transparency in Coverage” Final Rule… Thomas Sullivan Dec 7, 2021 0 Earlier this year, the United States Centers for Medicare and Medicaid Services (CMS) announced that it plans to delay the…
Anti Kickback Arthrex Reaches $16 Million Settlement Over Alleged False Claims Act… Thomas Sullivan Dec 6, 2021 0 On November 8, 2021, the United States Department of Justice (DOJ) announced that it reached a settlement agreement with…
CMS CMS Announces Increased Fines for Transparency Violations Thomas Sullivan Dec 3, 2021 0 In early November 2021, in the 2022 Hospital Outpatient Prospective Payment System Final Rule, the United States Centers for…
CMS CMS Releases Data on Medicare Advantage and Part D Star Ratings Thomas Sullivan Dec 2, 2021 0 According to data recently released by the Centers for Medicare and Medicaid Services (CMS), nearly 70% of Medicare Advantage (MA)…
CMS CMS Finalizes 2022 Medicare Physician Fee Schedule Thomas Sullivan Dec 1, 2021 0 On November 2, CMS the Centers for Medicare and Medicaid Services (CMS) finalized its calendar year (CY) 2022 updates to the…
Medical Legal 340B Legal Fight Sees Dueling Opinions Thomas Sullivan Nov 30, 2021 0 The fight over the 340B program between pharmaceutical companies and the United States Department of Health and Human Services…